Restore Medical Solutions

Founded in 2012 and headquartered in Memphis, US, Restore Medical Solutions specializes in advanced sterilization technologies.60 mn.The company specializes in providing advanced sterilization solutions designed to enhance surgical efficiency and ensure a pathogen-free environment during surgical procedures. Their core offerings include state-of-the-art sterilization methods such as hydrogen peroxide vapor sterilization, plasma sterilization, and automated sterilization systems equipped with advanced monitoring features. These technologies specifically target the reduction of microbial contamination on surgical instruments, aiming to prevent healthcare-associated infections, which are a significant concern in medical settings. The end users of these products are primarily healthcare facilities, including hospitals and surgical centers, which rely on these sterilization solutions to improve patient safety and optimize surgical workflows.Revenue generation for the company is largely driven by direct sales of its sterilization technologies to healthcare institutions, as well as potential partnerships with medical equipment distributors. The typical transaction structure involves long-term contracts with hospitals, where these facilities procure sterilization equipment and services under specified terms tailored to their operational needs. The company also offers subscription-based maintenance and support services, ensuring that clients receive continued assistance for their sterilization systems, which enhances customer loyalty and retention. Pricing for these advanced sterilization solutions reflects their premium positioning in the market, with individual product costs aligned to the technological sophistication and operational benefits they deliver.25 mn from August 2016 to enhance its product development efforts and expand its market presence. Upcoming products are being designed to further improve the efficiency and effectiveness of sterilization processes. The company is also targeting expansion into new geographic regions, including additional markets in Asia, with a focus on establishing operations there by 2024, thereby broadening its client base and enhancing service delivery.

1. Series A

   Jul 9, 2015

   Amount

   $1.6M

   Investors

   Locked

2. Series A

   Dec 11, 2012

   Amount

   $1M

   Investors

   Locked